LifeSteps Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Buy
263
+10
+4% +$10.2K 0.15% 77
2026
Q1
$233K Sell
253
-15
-6% -$15.2K 0.15% 85
2025
Q4
$288K Sell
268
-86
-24% -$82.2K 0.18% 75
2025
Q3
$270K Sell
354
-28
-7% -$20.8K 0.17% 76
2025
Q2
$298K Buy
382
+91
+31% +$70.7K 0.2% 74
2025
Q1
$240K Sell
291
-58
-17% -$48.3K 0.19% 74
2024
Q4
$269K Sell
349
-10
-3% -$8.28K 0.21% 72
2024
Q3
$318K Buy
359
+60
+20% +$53.9K 0.25% 63
2024
Q2
$271K Hold
299
0.22% 66
2024
Q1
$233K Buy
+299
New +$213K 0.18% 75

Other funds holding LLY

LifeSteps Financial's LLY Position: Q2 2026 in Review

LifeSteps Financial increased its Eli Lilly (LLY) stake by 4% in Q2 2026, buying an estimated $10.2K and bringing the position to 263 shares worth $315K. The position accounts for 0.15% of the portfolio, ranked #77.

LifeSteps Financial first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $318K in Q3 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LifeSteps Financial held 263 shares of Eli Lilly worth $315K as of Q2 2026.
  • LifeSteps Financial bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.15% of LifeSteps Financial's portfolio in Q2 2026, its #77 holding.
  • LifeSteps Financial first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • LifeSteps Financial's Eli Lilly position peaked at $318K in Q3 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.